INVITRO METABOLISM OF ETOPOSIDE (VP-16-213) BY LIVER-MICROSOMES AND IRREVERSIBLE BINDING OF REACTIVE INTERMEDIATES TO MICROSOMAL PROTEINS

被引：80

作者：

HAIM, N

NEMEC, J

ROMAN, J

SINHA, BK

机构：

[1] NCI,CLIN ONCOL BRANCH,BLDG 10,RM 6N-119,BETHESDA,MD 20892

[2] UNIFORMED SERV UNIV HLTH SCI,DIV CLIN PHARMACOL,BETHESDA,MD 20814

[3] NCI,FREDERICK CANC RES FACIL,CHEM SYNTH & ANAL LABS,FREDERICK,MD 21701

来源：

关键词：

D O I：

10.1016/0006-2952(87)90362-5

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：527 / 536

页数：10

共 35 条

[1] AMES MM, 1983, CANCER RES, V43, P500
[2] BACHUR NR, 1978, CANCER RES, V38, P1745
[3] BEND JR, 1972, J PHARMACOL EXP THER, V183, P206
[4] COLOMBO T, 1982, CANCER CHEMOTH PHARM, V7, P127
[5] CREAVEN PJ, 1982, CANCER CHEMOTH PHARM, V7, P133
[6] DINCALCI M, 1986, CANCER RES, V46, P2566
[7] DOW LW, 1983, CANCER RES, V43, P5699
[8] EVANS WE, 1982, CANCER CHEMOTH PHARM, V7, P147
[9] INHIBITION OF HEPATIC OXIDATIVE XENOBIOTIC METABOLISM BY PIPERONYL BUTOXIDE
FRANKLIN, MR
[J]. BIOCHEMICAL PHARMACOLOGY, 1972, 21 (24) : 3287 - +
[10] GRAM TE, 1974, DRUG METAB DISPOS, V2, P254